| Tretinoin | Approved Investigational Nutraceutical | WDR74 | 54663 |
downregulated | Tretinoin results in decreased expression of WDR74 mRNA | 11q12.3 | |
| Tretinoin | Approved Investigational Nutraceutical | WDR86 | 349136 |
upregulated | Tretinoin results in increased expression of WDR86 mRNA | 7q36.1 | |
| Tretinoin | Approved Investigational Nutraceutical | WDR89 | 112840 |
downregulated | Tretinoin results in decreased expression of WDR89 mRNA | 14q23.2 | |
| Tretinoin | Approved Investigational Nutraceutical | WEE1 | 7465 |
downregulated | Tretinoin results in decreased expression of WEE1 mRNA | 11p15.4 | |
| Tretinoin | Approved Investigational Nutraceutical | WFDC2 | 10406 |
upregulated | Tretinoin results in increased expression of WFDC2 mRNA | 20q13.12 | |
| Tretinoin | Approved Investigational Nutraceutical | WIPF1 | 7456 |
downregulated | Tretinoin results in decreased expression of WIPF1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | WIPF1 | 7456 |
upregulated | Tretinoin results in increased expression of WIPF1 mRNA | 2q31.1 | |
| Tretinoin | Approved Investigational Nutraceutical | WIPF3 | 644150 |
upregulated | Tretinoin results in increased expression of WIPF3 mRNA | 7p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | WIPI1 | 55062 |
upregulated | Tretinoin results in increased expression of WIPI1 mRNA | 17q24.2 | |
| Tretinoin | Approved Investigational Nutraceutical | WLS | 79971 |
upregulated | Tretinoin results in increased expression of WLS mRNA | 1p31.3 | |
| Tretinoin | Approved Investigational Nutraceutical | WNK1 | 65125 |
downregulated | Tretinoin results in decreased expression of WNK1 mRNA | 12p13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | WNK3 | 65267 |
downregulated | Tretinoin results in decreased expression of WNK3 mRNA | Xp11.22 | |
| Tretinoin | Approved Investigational Nutraceutical | WNT10A | 80326 |
downregulated | Tretinoin results in decreased expression of WNT10A mRNA | 2q35 | |
| Tretinoin | Approved Investigational Nutraceutical | WNT2 | 7472 |
downregulated | Tretinoin results in decreased expression of WNT2 mRNA | 7q31.2 | |
| Tretinoin | Approved Investigational Nutraceutical | WNT3 | 7473 |
upregulated | Tretinoin results in increased expression of WNT3 mRNA | 17q21.31-q21.32 | |
| Tretinoin | Approved Investigational Nutraceutical | WNT5A | 7474 |
upregulated | Tretinoin results in increased expression of WNT5A mRNA | 3p14.3 | |
| Tretinoin | Approved Investigational Nutraceutical | WNT5B | 81029 |
downregulated | Tretinoin results in decreased expression of WNT5B mRNA | 12p13.33 | |
| Tretinoin | Approved Investigational Nutraceutical | WSB1 | 26118 |
upregulated | Tretinoin results in increased expression of WSB1 mRNA | 17q11.1 | |
| Tretinoin | Approved Investigational Nutraceutical | WT1 | 7490 |
downregulated | Tretinoin results in decreased expression of WT1 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | WT1 | 7490 |
downregulated | Tretinoin results in decreased expression of WT1 mRNA alternative form | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | WT1 | 7490 |
upregulated | Tretinoin results in increased expression of WT1 mRNA | 11p13 | |
| Tretinoin | Approved Investigational Nutraceutical | WTAP | 9589 |
upregulated | Tretinoin results in increased expression of WTAP mRNA | 6q25.3 | |
| Tretinoin | Approved Investigational Nutraceutical | WWTR1 | 25937 |
upregulated | Tretinoin results in increased expression of WWTR1 mRNA | 3q25.1 | |
| Tretinoin | Approved Investigational Nutraceutical | XAF1 | 54739 |
upregulated | Tretinoin results in increased expression of XAF1 mRNA | 17p13.2 | |
| Tretinoin | Approved Investigational Nutraceutical | XBP1 | 7494 |
upregulated | Tretinoin results in increased expression of XBP1 mRNA alternative form | 22q12.1 | |